Diseases and ConditionsNews - Page 1

Sugemalimab approved to treat adult patients with non-small cell lung cancer    

The MHRA has approved the medicine sugemalimab (Eqjubi) to treat adult patients with non-small cell lung cancer. Read more here.

CMT Awareness Month: Raising awareness of a little-known condition

Many people are not aware of CMT disease, which can make everyday living and early medical diagnosis more difficult. Read more here.

The Université de Sherbrooke’s interdisciplinary approach for studying cancer in all its complexity

The Université de Sherbrooke's IRCUS is developing innovative interdisciplinary research to reduce the impact of cancer on affected people.

New saliva-based prostate cancer test could save NHS £500m

A revolutionary new prostate cancer test, which can be taken at home, could lead to thousands of earlier diagnoses for the NHS.

$7m ARPA-H funding will advance lung infection treatment

Researchers have been awarded up to $7m from ARPA-H to conduct research under the PROTECT project for lung infection treatment.

Artificial pancreas revolutionises type 1 diabetes care for thousands of NHS patients

The NHS will provide tens of thousands of children and eligible adults with type 1 diabetes access to an 'artificial pancreas' device.

AI unlocks new path to personalised cancer treatments

Researchers are leveraging AI and molecular simulations to uncover new pathways for personalised cancer treatments.

Rice University awarded $18m to advance tumour removal technology

New funding will support the development of a new system to enhance the accuracy of tumour removal in breast, head and neck cancer.

Machine learning algorithm achieves 98% disease detection accuracy via tongue analysis

A new machine learning algorithm has demonstrated an impressive 98% accuracy in diagnosing various diseases.

NHS launches world first gene therapy for thalassaemia patients

NHS patients with beta thalassaemia will be among the first in the world to benefit from a pioneering gene therapy known as Casgevy.

Defence Therapeutics advances radio-immuno-conjugates with CNRI-H Program approval

Defence Therapeutics Inc. has announced a significant milestone in its radio-immuno-conjugates project. Find out more.

AI enhances analysis of heart scans, saving NHS resources

Researchers have developed a groundbreaking AI method that improves the accuracy and efficiency of analysing MRI heart scans.

Could AI help detect cancer early?

A new study indicates that doctors may soon be able to use AI to detect cancer in patients, allowing for earlier treatment.

Parkinson’s disease stages monitored with smartwatches

Research suggests that widely used smartwatches could be used to monitor Parkinson’s disease stages in patients.

Innovation News Network - Free Digital eBook Library

Innovation News Network - Global Innovation Partners

Special Reports

Partner News

Special Reports Cont'd

Partner News Cont'd